NASDAQ · SERVICES-MEDICAL LABORATORIES · LARGE CAP
RadNet, Inc. RDNT
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.0B
▲ 11.5% vs FY2024
EPS · FY25
$-0.25
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-1.9%
Net margin · FY25
-0.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.0B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 1 cents on every revenue dollar this year.
Per share
USD -0.25
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-1.9%
Return on equity, FY2025
ROE
Operating margin3.0%
Net margin-0.9%
Return on assets-0.5%
Each USD of equity lost 2 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+13.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+12.6%
+13.7%
+9.7%
+24.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years+43.4%
Change, 10 years+60.0%
The share count grew 43% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.8B
total assets, end of FY2025
Total assetsUSD 3.8B
EquityUSD 1.1B
CashUSD 767.2M
Gross debtUSD 1.1B
Net debtUSD 322.7M
Current ratio1.76×
Net debt stands at 30% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
2.0
1.8
1.6
1.4
1.3
1.1
1.2
1.0
0.9
0.9
0.8
0.7
0.7
0.6
0.6
0.1
0.5
Operating income $B
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.1
0.0
0.0
0.0
Net income $B
−0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
EPS, diluted $
−0.25
0.04
0.05
0.17
0.46
−0.29
0.29
0.66
0.00
0.15
0.17
0.03
0.05
1.52
0.19
−0.35
−0.06
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−1.9
0.4
0.6
3.8
12.5
−9.4
10.6
34.2
0.1
16.3
34.9
279.9
·
·
·
·
·
Shares out B
0.07
0.07
0.07
0.06
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.04
0.04
0.04
0.04
0.04
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
48 of 48
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed